{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:02Z","timestamp":1786649762996,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the prevalence of hypertensive phase (HP) and failure in patients who underwent Ahmed Glaucoma Valve (AGV) implantation and identify the possible risk factors for both HP and failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cross-sectional, observational study was conducted. Medical records of patients who underwent AGV implantation and had at least 1 year of follow-up were reviewed. HP was defined as an intraocular pressure (IOP) greater than 21 mmHg between the first week and the third postoperative month not attributable to other causes. Success was defined as an IOP between 6 and 21 mmHg, with preservation of light perception and no additional glaucoma surgeries. Statistical analysis was conducted to identify possible risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 193 eyes of 177 patients were included. HP was present in 58%; a higher preoperative IOP and younger age were associated with HP. Pseudophakic or aphakic eyes had a lower HP rate. Failure was present in 29%; neovascular glaucoma, worse basal best corrected visual acuity (BCVA), higher baseline IOP, and postoperative complications were linked to a higher likelihood of failure. No difference in the HP rate between the failure and success groups was found.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A higher baseline IOP and younger age are associated with HP development; pseudophakia and aphakia might be protective factors. Factors for AGV failure are a worse BCVA, neovascular glaucoma, postoperative complications, and a higher baseline IOP. At 1 year, a higher number of medications were needed to achieve IOP control in the HP group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2541_22","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T03:49:47Z","timestamp":1684295387000},"page":"1966-1971","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of hypertensive phase and outcomes in patients with Ahmed valve implantation at one year of follow-up and evaluation of associated risk factors"],"prefix":"10.4103","volume":"71","author":[{"given":"Jorge","family":"Neaves-Mendez","sequence":"first","affiliation":[{"name":"Asociaci\u00f3n para Evitar la Ceguera en M\u00e9xico I. A. P., Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Hernandez-Oteyza","sequence":"additional","affiliation":[{"name":"Asociaci\u00f3n para Evitar la Ceguera en M\u00e9xico I. A. P., Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Alvarez-Ascencio","sequence":"additional","affiliation":[{"name":"Asociaci\u00f3n para Evitar la Ceguera en M\u00e9xico I. A. P., Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Campos-Martinez","sequence":"additional","affiliation":[{"name":"Departamento de Neurodesarrollo y Fisiolog\u00eda, Divisi\u00f3n de Neurociencias, Instituto de Fisiolog\u00eda Celular, UNAM. Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Jimenez-Roman","sequence":"additional","affiliation":[{"name":"Asociaci\u00f3n para Evitar la Ceguera en M\u00e9xico I. A. P., Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"R1-20251006","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","article-title":"Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up","volume":"153","author":"Gedde","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"R2-20251006","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.survophthal.2018.10.008","article-title":"Etiology and management of the hypertensive phase in glaucoma drainage-device surgery","volume":"64","author":"Fargione","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R3-20251006","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0002-9394(03)00630-5","article-title":"Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve","volume":"136","author":"Nouri-Mahdavi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R4-20251006","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/IJG.0000000000000131","article-title":"Early aqueous suppressant therapy on hypertensive phase following glaucoma drainage device procedure: A randomized prospective trial","volume":"25","author":"Law","year":"2016","journal-title":"J Glaucoma"},{"key":"R5-20251006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/IJG.0000000000000544","article-title":"Hypertensive phase following silicon plate Ahmed glaucoma valve implantation","volume":"26","author":"Dubey","year":"2017","journal-title":"J Glaucoma"},{"key":"R6-20251006","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3341\/kjo.2017.0102","article-title":"Effects of early postoperative intraocular pressure after ahmed glaucoma valve implantation on long-term surgical outcomes","volume":"32","author":"Jeong","year":"2018","journal-title":"Korean J Ophthalmol"},{"key":"R7-20251006","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1111\/aos.12916","article-title":"Risk factors for the hypertensive phase after implantation of a glaucoma drainage device","volume":"94","author":"Jung","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"R8-20251006","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1111\/aos.12571","article-title":"Serial changes in the bleb wall after glaucoma drainage implant surgery: Characteristics during the hypertensive phase","volume":"93","author":"Jung","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"R9-20251006","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/IJG.0000000000000141","article-title":"Combined phacoemulsification and ahmed glaucoma drainage implant surgery for patients with refractory glaucoma and cataract","volume":"25","author":"Valenzuela","year":"2016","journal-title":"J Glaucoma"},{"key":"R10-20251006","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1097\/IJG.0000000000000249","article-title":"Hypertensive phase following silicone plate ahmed glaucoma valve implantation","volume":"25","author":"Won","year":"2016","journal-title":"J Glaucoma"},{"key":"R11-20251006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10792-021-02009-3","article-title":"Risk factors for hypertensive phase after Ahmed glaucoma valve implantation","volume":"42","author":"\u00d6zalp","year":"2022","journal-title":"Int Ophthalmol"},{"key":"R12-20251006","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s10792-017-0654-8","article-title":"Hypertensive phase and its association with surgical outcomes in Baerveldt implantation","volume":"38","author":"Chansangpetch","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R13-20251006","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2147\/OPTH.S292150","article-title":"Risk factors for failure in double-plate tube surgery for refractory glaucoma: 25 years surgical experience","volume":"15","author":"Duch","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R14-20251006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ogla.2020.07.006","article-title":"Risk factors for glaucoma drainage device failure and complication in the pediatric population","volume":"4","author":"Medert","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"R15-20251006","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00268-003-7397-6","article-title":"Aging and wound healing","volume":"28","author":"Gosain","year":"2004","journal-title":"World J Surg"},{"key":"R16-20251006","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1097\/IJG.0b013e3182955d73","article-title":"Clinical experience with a novel glaucoma drainage implant","volume":"23","author":"Kim","year":"2014","journal-title":"J Glaucoma"},{"key":"R17-20251006","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ophtha.2022.07.003","article-title":"Treatment outcomes in the primary tube versus trabeculectomy study after 5 years of follow-up","volume":"129","author":"Gedde","year":"2022","journal-title":"Ophthalmology"},{"key":"R18-20251006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3341\/kjo.2017.0105","article-title":"Factors associated with outcomes of combined phacoemulsification and Ahmed glaucoma valve implantation","volume":"32","author":"Kwon","year":"2018","journal-title":"Korean J Ophthalmol"},{"key":"R19-20251006","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.ophtha.2016.06.035","article-title":"The Ahmed Versus Baerveldt study: Five-year treatment outcomes","volume":"123","author":"Christakis","year":"2016","journal-title":"Ophthalmology"},{"key":"R20-20251006","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2014.08.043","article-title":"Five-year treatment outcomes in the Ahmed Baerveldt comparison study","volume":"122","author":"Budenz","year":"2015","journal-title":"Ophthalmology"},{"key":"R21-20251006","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bjophthalmol-2019-313942","article-title":"Long-term outcome of low-cost glaucoma drainage device (Aurolab aqueous drainage implant) compared with Ahmed glaucoma valve","volume":"104","author":"Pandav","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R22-20251006","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5005\/jp-journals-10008-1168","article-title":"Surgical outcome of Ahmed valve implantation in Mexican patients with neovascular glaucoma","volume":"8","author":"Hernandez-Oteyza","year":"2014","journal-title":"J Curr Glaucoma Pract"},{"key":"R23-20251006","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/IJG.0b013e3181ca7f7f","article-title":"The Ahmed glaucoma valve in patients with and without neovascular glaucoma","volume":"19","author":"Netland","year":"2010","journal-title":"J Glaucoma"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2541_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:09Z","timestamp":1786647489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2541_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2541_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"2022-10-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}